Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Zika, Ebola, Bird Flu, HIV, etc. are today’s murderers. However, malaria is the ancient, current’s and futures’ slaughterer. The
main measures that are in action to minimize malaria’s distractions can be grouped into 3 options: prompting diagnoses
and treatment with anti-malaria drugs; eliminating the vector by different measures and prophylaxis-vaccination. By such
measures, the burden of malaria infection decreases, but couldn’t eradicate. Instead, may appear some genetically modified
Plasmodium and even the mosquito itself! For postulating our new idea on minimizing such dangerous tendencies, since June
2016, through social media and seminar, we deal with stakeholders on the following: if Anopheles couldn’t suck infected blood
during its lifespan (maximum a month), it will die without transmitting the disease to a healthy person. Hence, temporary (for
≤100 days) dislocate the patient from the area, where the mosquito population is high, not only more effective than using only
bed nets or killing the Anopheles, but also gives extra dozens of advantages. A quarter of them:
• Controllable treatment;
• Minimize plasmodium’s adaptation (modification) inside its host!;
• Considering the right of non-infected people: “they have also a right not to be infected!”
• During dislocation, skilling-training the patient for his futurity.
Thus along with the 3 options, we should try the mentioned new option. During the presentation, except for the detailed plan
of realizing our option, we can show:
• lack of sufficient awareness not only in developing countries but also of developed
• revealing the drawbacks of the above mentioned 3 options that the world is using to eradicate malaria
• propose 2-3 chemical agents, which may distract the life cycle of the vector
Biography
Dessalegn has completed his PhD at the age of 27 years from Institute of Biochemistry (Moscow, Russia). Now he is an Assistant Professor at Addis Ababa Science & Technology University (Addis Ababa, Ethiopia). He has published more than 7 papers in reputed journals.